These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8808010)

  • 1. Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results.
    Ranke MB; Savage MO; Chatelain PG; Preece MA; Rosenfeld RG; Blum WF; Wilton P
    Horm Res; 1995; 44(6):253-64. PubMed ID: 8808010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.
    Backeljauw PF; Underwood LE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3312-7. PubMed ID: 8784089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
    Tonella P; Flück CE; Mullis PE
    Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes.
    Ranke MB; Savage MO; Chatelain PG; Preece MA; Rosenfeld RG; Wilton P
    Horm Res; 1999; 51(3):128-34. PubMed ID: 10461018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R; Jakubowicz S
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF; Cotterill AM; Postel-Vinay MC; Ranke MB; Savage MO; Wilton P
    Acta Paediatr Suppl; 1994 Apr; 399():117-24. PubMed ID: 7949595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E; Kriström B; Jonsson B; Albertsson-Wikland K;
    BMC Endocr Disord; 2015 Dec; 15():84. PubMed ID: 26682747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
    Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome.
    Burren CP; Woods KA; Rose SJ; Tauber M; Price DA; Heinrich U; Gilli G; Razzaghy-Azar M; Al-Ashwal A; Crock PA; Rochiccioli P; Yordam N; Ranke MB; Chatelain PG; Preece MA; Rosenfeld RG; Savage MO
    Horm Res; 2001; 55(3):125-30. PubMed ID: 11549873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
    Chernausek SD; Backeljauw PF; Frane J; Kuntze J; Underwood LE;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):902-10. PubMed ID: 17192294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
    Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
    Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
    Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.
    Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S
    Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.